000 03510nam a22003615i 4500
001 279796
003 MX-SnUAN
005 20160429153958.0
007 cr nn 008mamaa
008 150903s2008 xxu| o |||| 0|eng d
020 _a9780387713762
_99780387713762
024 7 _a10.1007/9780387713762
_2doi
035 _avtls000332141
039 9 _a201509030217
_bVLOAD
_c201404122034
_dVLOAD
_c201404091803
_dVLOAD
_y201402041021
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aQR180-189.5
100 1 _aJirillo, Emilio.
_eeditor.
_9304321
245 1 0 _aHepatitis C Virus Disease :
_bImmunobiology and Clinical Applications /
_cedited by Emilio Jirillo.
264 1 _aNew York, NY :
_bSpringer New York,
_c2008.
300 _brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aInnate Immunity in Type C Hepatitis -- Mechanisms of Interferon Action and Resistance in Chronic Hepatitis C Virus Infection: Lessons Learned from Cell Culture Studies -- Immunological Parameters Influencing Adaptive Immune Responses to the Hepatitis C Virus -- Immune Responses Against the Hepatitis C Virus and the Outcome of Therapy -- Other Microbial Components Associated with Hepatitis C Virus Infection: Their Effects on Interferon-?/Ribavirin Treatment -- Interferon-Induced Effector Proteins and Hepatitis C Virus Replication -- Treatment of Chronic Hepatitis C with Different Genotypes -- Interferon Treatment of Hepatitis C Virus Infection: From Basic Biology to Clinical Application -- Interferon-Based Therapy for Hepatitis C Virus Infections -- Treatment of Chronic Hepatitis C in “Difficult-to-Treat” Patients in the Clinical Setting -- Effects of Combined IFN-Alpha/Ribavirin Treatment in HCV Disease-Related Progression -- Pegylated Interferons: Clinical Applications in the Management of Hepatitis C Infection.
520 _aThis comprehensive volume, written by experts in the field, emphasizes the most recent advances on the Hepatitis C virus infection (HCV) moving from basic research to clinical application. In spite of the numerous studies on HCV infection, its pathogenesis and medical treatment have not been fully explained. The first chapters of this volume analyize the full spectrum of immune responses to HCV taking into account either innate or adoptive immunity involvement. The volume also includes a series of contributions which explain the state of art of IFN-alpha treatment in HCV patients and the effectiveness of therapy also in relation to HCV genotypes. The use and applications of pegylated IFNs will also be discussed as well as the complicated HCV disease and its treatment. Hepatitis C Virus Disease: Immunobiology and Clinical Applications is an ideal volume for researchers, scientists, professionals, clinicians, physicians and graduate students in the fields of infectious disease, immunology, virology, microbiology, pharmacology and medicine.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9780387713755
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-71376-2
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c279796
_d279796